The present disclosure provides a water dispersible granule formulation comprising from about 5% to about 80% (w/w) of monensin； from about 1% to about 20% (w/w) of one or more surfactants； from about 1% to about 30% (w/w) of one or more binders； from about 1% to about 90% (w/w) of one or more fillers； and water up to about 2% (w/w). The present disclosure also provides a process for the preparation of a water dispersible monensin granule formulation. The present disclosure further provides a method of administering a therapeutically effective amount of a water dispersible monensin granule formulation to an animal.
